ABN AMRO INVESTMENT SOLUTIONS
Position in GILD — Gilead Sciences, Inc.
CIK 2080520
PARIS CEDEX 008, I0
Position in GILD
as of Jun 30, 2026
· filed Jul 23, 2026
Position Value
$32,391,806
+$8,413,199 QoQ
Shares Held
256,386
+49.0% QoQ
Ownership
0.021%
of shares outstanding
% of Portfolio
0.28%
of 13F equity value
Holder Rank
#270
of 2,266 holders
Holding Since
Mar 2023
13 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026ABN AMRO INVESTMENT SOLUTIONS holds $622,809,129 across 9 Drug Manufacturers - General names. GILD ranks #5 (5.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
232,754 | $279,172,153 | |
| 2 | ABBV |
AbbVie Inc.
|
649,098 | $163,339,020 | |
| 3 | JNJ |
Johnson & Johnson
|
270,314 | $68,651,646 | |
| 4 | MRK |
Merck & Co., Inc.
|
309,009 | $39,707,656 | |
| 5 | GILD |
Gilead Sciences, Inc.
This page
|
256,386 | $32,391,806 | |
| 6 | AMGN |
Amgen Inc
|
56,533 | $20,471,729 | |
| 7 | PFE |
Pfizer Inc
|
366,987 | $8,837,046 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
147,546 | $8,501,599 |
All Filings in GILD
Export CSV
13 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $32,391,806 | 256,386 | Shares | Defined | 2026-07-23 | |
| 2026-03-31 | $23,978,607 | 172,050 | Shares | Other | 2026-05-12 | |
| 2025-12-31 | $21,804,637 | 177,649 | Shares | Defined | 2026-02-06 | |
| 2025-09-30 | $5,431,563 | 48,933 | Shares | Defined | 2025-11-07 | |
| 2025-06-30 | $5,299,364 | 47,798 | Shares | Defined | 2025-08-08 | |
| 2025-03-31 | $5,415,376 | 48,330 | Shares | Defined | 2025-08-27 | |
| 2024-12-31 | $3,238,861 | 35,064 | Shares | Defined | 2025-09-04 | |
| 2024-09-30 | $2,907,068 | 34,674 | Shares | Defined | 2025-09-04 | |
| 2024-06-30 | $2,418,365 | 35,248 | Shares | Defined | 2025-09-04 | |
| 2024-03-31 | $2,604,037 | 35,550 | Shares | Defined | 2025-09-05 | |
| 2023-12-31 | $76,371,448 | 942,741 | Shares | Defined | 2025-09-05 | |
| 2023-06-30 | $71,746,543 | 930,927 | Shares | Defined | 2025-09-05 | |
| 2023-03-31 | $77,108,833 | 929,358 | Shares | Defined | 2025-09-05 | |
| No filing history on record for this holder in this stock. | ||||||